Elanco Animal Health (ELAN) Tops Q1 EPS by 6c ; Offers Guidance

Elanco Animal Health (NYSE: ELAN) reported Q1 EPS of $0.37, $0.06 better than the analyst estimate of $0.31. Revenue for the quarter came in at $1.19 billion versus the consensus estimate of $1.17 billion.

GUIDANCE:

Elanco Animal Health sees FY2025 EPS of $0.80-$0.86, versus the consensus of $0.83. Elanco Animal Health sees FY2025 revenue of $4.51-4.58 billion, versus the consensus of $4.5 billion.

For earnings history and earnings-related data on Elanco Animal Health (ELAN) click here.

You May Also Be Interested In

• Apollo Global Management (APO) call put ratio 1 call to 6.8 puts a focus on a spreader of 9K contracts January 95 and 135 puts
• UBS Downgrades Apogee Therapeutics Inc (APGE) to Neutral
• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings